Cowen analyst Chris Schibutani initiates coverage on Repare Therapeutics (NASDAQ: RPTX) with a Outperform rating.The analyst comments "We see broad ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE